Myeloid ecotropic viral integration site-1 inhibition promotes apoptosis, suppresses proliferation of acute myeloid leukemia cells, accentuates the effects of anticancer drugs

References

• Appelbaum FR, Rowe JM, Radich J, et al. Acute myeloid leukemia. N Engl J Med. 1999;341(14):1051–1062.
   PubMed Web of Science ®Google Scholar
• Müller MR, Lennartz K, Boogen C, et al. Cytotoxicity of Adriamycin, idarubicin, and vincristine in acute myeloid leukemia: chemosensitization by verapamil in relation to P-glycoprotein expression. Ann Hematol. 1992;65(5):206–212.
   PubMed Web of Science ®Google Scholar
• Jiang SH, Li J, Dong FY, et al. Increased serotonin signaling contributes to the Warburg effect in pancreatic tumor cells under metabolic stress and promotes growth of pancreatic tumors in mice. Gastroenterology. 2017;277-291:2017.
   Google Scholar
• Hsu PP, Sabatini DM. Cancer cell metabolism: warburg and beyond. Cell. 2008;134:703–707.
   PubMed Web of Science ®Google Scholar
• Bhattacharya B, Mohd Omar MF, Soong R. The warburg effect and drug resistance. Brit J Pharmacol. 2016;173:970–979.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Peng H, Hong C, et al. PDGF promotes the warburg effect in pulmonary arterial smooth muscle cells via activation of the PI3K/AKT/mTOR/HIF-1α signaling pathway. Cell Physiol Biochem. 2017;42:1603–1613.
   PubMed Web of Science ®Google Scholar
• Jing L, Pan C, Guo L, et al. A new mechanism of trastuzumab resistance in gastric cancer: macc1 promotes the warburg effect via activation of the PI3K/AKT signaling pathway. J Hematol Oncol. 2016;9:76.
   PubMed Web of Science ®Google Scholar
• Zhang BM, Hao X, Chen BY, et al. Relationship between mitochondrial bound hexokinase and tumor development and PI3K/AKT signal pathway. World Latest Med Inform. 2016;16(77):1-3.
   Google Scholar
• Villaume K, Blanc M, Gouysse G, et al. VEGF Secretion by neuroendocrine tumor cells is inhibited by octreotide and by Inhibitors of the PI3K/AKT/mTOR pathway. Neuroendocrinology. 2010;91:268–278.
   PubMed Web of Science ®Google Scholar
• Su MA, Huang YT, Chen IT, et al. An invertebrate warburg effect: a shrimp virus achieves successful replication by altering the host metabolome via the PI3K-Akt-mTOR pathway. Plos Pathog. 2014;10:e1004196.
   PubMed Web of Science ®Google Scholar
• Moskow JJ, Bullrich F, Huebner K, et al. PBX1-related homeobox gene involved in myeloid leukemia in BXH-2 mice. Mol Cell Biol. 1995;15:5434–5443.
   PubMed Web of Science ®Google Scholar
• Smith JE, Bollekens JA, Inghirami G, et al. Cloning and mapping of the meis 1 gene, the human homolog of a leukemogenic gene. Genomics. 1997;43:99–103.
   PubMed Web of Science ®Google Scholar
• Thorsteinsdottir U, Kroon E, Jerome L, et al. Defining roles for Hox and meis 1 genes in induction of acute myeloid leukemia. Mol Cell Biol. 2001;21:224–234.
   PubMed Web of Science ®Google Scholar
• Adamaki M, Lambrou GI, Athanasiadou A, et al. HOXA9 and meis 1 gene overexpression in the diagnosis of childhood acute leukemias: significant correlation with relapse and overall survival. Leuk Res. 2015;39:874–882.
   PubMed Web of Science ®Google Scholar
• Argiropoulos B, Yung E, Xiang P, et al. Linkage of the potent leukemogenic activity of meis 1 to cell-cycle entry and transcriptional regulation of cyclin D3. Blood. 2010;115:4071–4082.
   PubMed Web of Science ®Google Scholar
• Ho TT, He X, Beck WT. Abstract 796: novel mechanisms of drug resistance in leukemia cells associated with changes in HoxA9 and microRNA expression. Cancer Res. 2012;72: 796–796.
   Google Scholar
• Gundry M, Brunetti L, Sheppard H, et al. Nuclear relocalization of mutant npm1 induces downregulation of hox/meis 1, terminal differentiation, and cell cycle arrest. Exp Hematol. 2017;53:S45.
   Google Scholar
• Roychoudhury J, Clark JP, Graciamaldonado G, et al. Meis 1 regulates an HLF-oxidative stress axis in MLL-fusion gene leukemia. Blood. 2015;125:2544.
   PubMed Web of Science ®Google Scholar
• Crijns AP, De GP, Geerts D, et al. Meis 1 and PBX homeobox proteins in ovarian cancer. Eur J Cancer. 2007;43:2495–2505.
   PubMed Web of Science ®Google Scholar
• Arabanian LS, Johansson P, Staffas A, et al. The endothelin receptor type A is a downstream target of Hoxa9 and Meis1 in acute myeloid leukemia. Leukemia Res. 2018. DOI:10.1016/j.leukres.2018.10.005.
   PubMed Web of Science ®Google Scholar
• Xu H, Mi R, Fan R, et al. Effects of thalidomide combined with interferon on inhibiting Kasumi-1 cell proliferation. Adv Clin Exp Med. 2016;25(3):403–408.
   PubMed Web of Science ®Google Scholar
• Johng D, Torga G, Ewing CM, et al. HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer. Prostate. 2019;79(4):414–424.
   PubMed Web of Science ®Google Scholar
• Zargari S, Negahban Khameneh S, Rad A, et al. MEIS1 promotes expression of stem cell markers in esophageal squamous cell carcinoma. BMC Cancer. 2020 20;20(1):789.
   PubMed Web of Science ®Google Scholar
• Mahmoud AI, Kocabas F, Muralidhar SA, et al. Meis1 regulates postnatal cardiomyocyte cell cycle arrest. Nature. 2013 9;497(7448):249–253.
   PubMed Web of Science ®Google Scholar
• Lyu S, Xing H, Liu Y, et al. Deficiency of Meis1, a transcriptional regulator, in mice and worms: neurochemical and behavioral characterizations with implications in the restless legs syndrome. J Neurochem. 2020;155(5):522–537.
   PubMed Web of Science ®Google Scholar
• Baines P, Limaye M, Hoy T, et al. Drug-resistance in acute myeloid-leukemia. Br J Haematol. 1993;84: 2–2.
   Web of Science ®Google Scholar
• Taisuke M, Shun D, Yasuyuki S. Lactic acid promotes cell survival by blocking autophagy of B16F10 mouse melanoma cells under glucose deprivation and hypoxic conditions. Biol Pharm Bull. 2019;42(5):837–839.
   PubMed Web of Science ®Google Scholar
• Zheng YF, Chen HR, Zhao Y, et al. Knockdown of FBXO22 inhibits melanoma cell migration, invasion and angiogenesis via the HIF-1α/VEGF pathway. Invest New Drugs. 2020;38(1):20–28.
   PubMed Web of Science ®Google Scholar
• Spitz DR, Sim JE, Ridnour LA, et al. Glucose deprivation-induced oxidative stress in human tumor cells. A fundamental defect in metabolism? Ann N Y Acad Sci. 2000;899:349–362.
   PubMed Web of Science ®Google Scholar
• Cottrill KA, Chan SY. Metabolic dysfunction in pulmonary hypertension: the expanding relevance of the warburg effect. Eur J Clin Invest. 2013;43:855–865.
   PubMed Web of Science ®Google Scholar
• Paulin R, Michelakis ED. The metabolic theory of pulmonary arterial hypertension. Circ Res. 2014;115:148–164.
   PubMed Web of Science ®Google Scholar
• Robey RB, Hay N. Is Akt the “Warburg kinase”?-Akt-energy metabolism interactions and oncogenesis. Semin Cancer Biol. 2009;19:25–31.
   PubMed Web of Science ®Google Scholar
• Perez J, Hill B, Benavides G, et al. Role of cellular bioenergetics in smooth muscle cell proliferation induced by platelet-derived growth factor. Biochem J. 2010;428:255–267.
   PubMed Web of Science ®Google Scholar
• Houssaini A, Abid S, Mouraret N, et al. Rapamycin reverses pulmonary artery smooth muscle cell proliferation in pulmonary hypertension. Am J Resp Cell Mol. 2013;48:568–577.
   PubMed Web of Science ®Google Scholar
• Nuruzzaman M, Zhang R, Cao HZ, et al. Plant pleiotropic drug resistance transporters: transport mechanism, gene expression, and function. J Integr Plant Biol. 2014;56:729–740.
   PubMed Web of Science ®Google Scholar
• Murono K, Tsuno NH, Kawai K, et al. SN-38 overcomes chemoresistance of colorectal cancer cells induced by hypoxia, through HIF1α. Anticancer Res. 2012;32:865–872.
   PubMed Web of Science ®Google Scholar
• Flamant L, Notte A, Ninane N, et al. Anti-apoptotic role of HIF-1 and AP-1 in paclitaxel exposed breast cancer cells under hypoxia. Mol Cancer. 2010;9:191.
   PubMed Web of Science ®Google Scholar
• Zhang QG, Raz L, Wang R, et al. Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation. J Neurosci. 2009;29:13823.
   PubMed Web of Science ®Google Scholar